You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-11 1 Defendants for patent infringement of United States Patent Nos. 5,540,938 (the “’938 patent”), 8,007,826 (the …the “’826 patent”), 8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the “’685… patent, ’703 patent, and ’685 patent, and the right to sue for infringement thereof. 7. …the ’938 patent. A copy of the ’938 patent is attached hereto as Exhibit A. The ’826 Patent 25… for the ’938 patent as July 30, 2018, the ’826 patent as May 26, 2027, the ’437 patent as December 22 External link to document
2016-08-05 29 States Patent Nos. 5,540,938, 8,077,826. 8.354,437, 8,440,703 , and 8.663,685 (the "Patents"…CONSENT JUDGMENT WHEREAS. this action for patent infringement has been brought by Plaintiffs Acorda…all proper in this Court. 2. The Patents are enforceable and valid. Case 1:14-cv-00917-LPS…353 3. Alkem has infringed the Patents pursuant to 35 U.S.C. §271(e)(2) by filing Abbreviated…any of its Affiliates, until the license to the Patents provided in the Settlement Agreement becomes External link to document
2014-07-11 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826; 8,354,437; 8,440,703…2014 5 August 2016 1:14-cv-00917 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.